6974-85-2

Basic information

• Product Name: ETHYL 2-BROMOHEXANOATE
• Synonyms: 2-BROMOHEXANOIC ACID ETHYL ESTER;ALPHA-BROMOHEXANOIC ACID ETHYL ESTER;ETHYL A-BROMOCAPROATE;ETHYL ALPHA-BROMOCAPROATE;ETHYL 2-BROMOCAPROATE;Ethyl 2-bromodecanoate;2-Bromodecanoic acid ethyl ester;Nsc22004
• CAS NO: 6974-85-2
• Molecular Formula: C₁₂H₂₃BrO₂
• Molecular Weight: 223.11
• EINECS: 210-455-9
• Mol File: 6974-85-2.mol

Chemical Properties

• Boiling Point: 213-215 °C(lit.)
• Flash Point: 204 °F
• Appearance: /
• Density: 1.221 g/mL at 25 °C(lit.)
• Vapor Pressure: 0.006mmHg at 25°C
• Refractive Index: n20/D 1.45(lit.)
• CAS DataBase Reference: ETHYL 2-BROMOHEXANOATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL 2-BROMOHEXANOATE(6974-85-2)
• EPA Substance Registry System: ETHYL 2-BROMOHEXANOATE(6974-85-2)

Safety Data

• Hazard Codes: C
• Statements: 22-34
• Safety Statements: 26-36/37/39
• RIDADR: UN 3265 8/PG 2
• WGK Germany: 3
• Hazardous Substances Data: 6974-85-2(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
ETHYL 2-BROMOHEXANOATE is used as a pharmaceutical intermediate for the synthesis of various drugs. Its chemical properties make it a valuable component in the development of new medications.
Used in Organic Synthesis:
ETHYL 2-BROMOHEXANOATE is used as a functional material or intermediate in the synthesis of other chemicals. Its reactivity and solubility characteristics contribute to its utility in creating a range of chemical products.

InChI:InChI=1/C12H23BrO2/c1-3-5-6-7-8-9-10-11(13)12(14)15-4-2/h11H,3-10H2,1-2H3

Upstream product

• 334-48-5 1-decanoic acid 
• 64-17-5 ethanol 
• 2623-95-2 2-bromodecanoic acid 
• 99217-33-1 α-bromodecanoyl chloride 
• 680859-92-1 2-acetyl-2-bromodecanoic acid ethyl ester 
• 24317-95-1 ethyl 2-octylacetoacetate 

Downstream Products

• 188699-86-7 2-[2-({3-[(E)-2-(7-Chloro-quinolin-2-yl)-vinyl]-phenylamino}-methyl)-phenoxy]-decanoic acid ethyl ester 
• 63538-45-4 2-{4-[4-(1-Carboxy-nonyloxy)-phenoxy]-phenoxy}-decanoic acid 
• 1374020-24-2 (RS)-2-[4-octanoylphenoxy]decanoic acid 
• 1374020-25-3 (R)-2-[4-octanoylphenoxy]decanoic acid, sodium salt 
• 1374020-29-7 (R)-2-[4-octanoylphenoxy]decanoic acid 
• 1374020-28-6 (S)-2-[4-octanoylphenoxy]decanoic acid (S)-lactamide ester 
• 1374020-27-5 (R)-2-[4-octanoylphenoxy]decanoic acid (S)-lactamide ester 
• 1374020-02-6 sodium (RS)-2-[4-octanoylphenoxy]decanoate 
• 1374020-23-1 ethyl (RS)-2-[4-octanoylphenoxy]decanoate 
• 58827-04-6 α-[p-(1-cycloheptenyl)-phenoxy]-decanoic acid ethyl ester 
• 38799-02-9 α-[p-(1-cyclohexenyl)-phenoxy]-decanoic acid ethyl ester 
• 33559-53-4 2-[4-(5-pyridin-3-yl-[1,2,4]oxadiazol-3-yl)-phenoxy]-decanoic acid ethyl ester 
• 33559-28-3 2-(4-hydroxycarbamimidoyl-phenoxy)-decanoic acid ethyl ester 
• 40843-11-6 4-(4-Chlorphenoxy)-α-phenoxy-caprinsaeure 

Relevant articles and documents

Synthesis and characterization of novel phosphonocarboxylate inhibitors of RGGT

Phosphonocarboxylate (PC) analogs of the anti-osteoporotic drugs, bisphosphonates, represent the first class of selective inhibitors of Rab geranylgeranyl transferase (RabGGTase, RGGT), an enzyme implicated in several diseases including ovarian, breast and skin cancer. Here we present the synthesis and biological characterization of an extended set of this class of compounds, including lipophilic derivatives of the known RGGT inhibitors. From this new panel of PCs, we have identified an inhibitor of RGGT that is of similar potency as the most active published phosphonocarboxylate, but of higher selectivity towards prenyl pyrophosphate synthases. New insights into structural requirements are also presented, showing that only PC analogs of the most potent 3rd generation bisphosphonates inhibit RGGT. In addition, the first phosphonocarboxylate-derived GGPPS weak inhibitor is reported.

Synthesis, characterization, and properties of copolyanhydrides based on 2-octylsuccinic acid and sebacic acid

2-Octylsuccinic acid and its copolyanhydrides with sebacic acid have been synthesized by melt polycondensation, and were characterized by Fourier transform infrared spectroscopy, 1H NMR, gel permeation chromatography, differential scanning calorimetry, and thermal gravimetric analysis. In vitro studies showed that all copolymers are degradable in phosphate buffer at 37°C. The release profiles of the hydrophilic model drug ciprofloxacin hydrochloride follow first-order release kinetics. CSIRO 2008.

One-pot synthesis of α-bromoesters and ketones from β-ketoesters and diketones using supported reagents system

A simple and efficient method has been developed for the synthesis of α-bromoesters and ketones from β-ketoesters and diketones in one pot using a supported reagents system, CuBr2/Al2O 3-Na2CO3/Al2O3, in which β-ketoester reacts first with CuBr2/Al2O3 and the product, α-bromo-β-ketoester, reacts with Na 2CO3/Al2O3 to give the final product, α-bromoesters in good yields.

Unnatural nucleosides and nucleotides. III. Preparation of 2-14C and 4-14C labelled 5-alkyluracils and 5-alkyl-2'-deoxyuridines

2-14C Labelled 5-alkyluracils were prepared by condensation of the diethylacetals of α-formyl-carbonic acid esters with 14C-thiourea. Compounds labelled at 4-C were synthesized by condensation of the labelled carboxylic acid derivatives with thiourea. β-Anomers of 5-alkyl-2'-deoxyuridines were obtained in a fairly good radiochemical yield. Alkyl substituents ranged from methyl to tetradecyl, isopropyl and tert-butyl.